Cariprazine in two dose strengths found effective for bipolar depression | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Cariprazine in two dose strengths found effective for bipolar depression

Publication year - 2019

Publication title -

the brown university psychopharmacology update

Language(s) - English

Resource type - Journals

eISSN - 1556-7532

pISSN - 1068-5308

DOI - 10.1002/pu.30444

Subject(s) - bipolar disorder , depression (economics) , medicine , psychiatry , depressive symptoms , placebo , antipsychotic , bipolar i disorder , schizophrenia (object oriented programming) , psychology , clinical psychology , anxiety , cognition , alternative medicine , mania , economics , macroeconomics , pathology

The atypical antipsychotic cariprazine was more effective than placebo in improving depressive symptoms in a Phase 3 study involving adults with bipolar disorder and a current depressive episode. Both 1.5 mg/day and 3 mg/day doses of the drug were found to be relatively safe and effective, researchers reported. Study results were published online March 8 in the American Journal of Psychiatry .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research